Record Earnings and Strong ROE
RGA reported adjusted operating earnings of $6.13 per share and a return on equity of 15.5%, exceeding intermediate-term targets.
Significant Capital Deployment
RGA deployed $1.4 billion of capital in 2024, which is more than 50% higher than in 2023, with a strong new business embedded value exceeding last year's total.
Growth in Asian Market
Strong growth in the Asian Traditional business, with favorable market conditions and successful product development, highlighted by new cancer treatment product in Korea selling over 2 million policies.
U.S. Traditional Segment Success
The U.S. Traditional segment experienced a strong quarter with over 20 new business wins, including a significant transaction with American National.
Increased Value of In-Force Business
The value of in-force business margins increased by $4.6 billion or 13.9% over the first three quarters of 2024.